Related Experiment Videos
Increased antibacterial activity of 15-residue murine lactoferricin derivatives
Abstract:
LFM W8 is a synthetic 15-residue lactoferricin derivative (H2N-EKCLRWQWEMRKVGG-COOH), corresponding to residues 16-30 of the mature murine lactoferrin protein except that the asparagine residue in position 8 of the native peptide is replaced with tryptophan. We have previously reported that the two tryptophan residues in positions 6 and 8 are of crucial importance for the antibacterial activity of many lactoferricin derivatives but, despite fulfilling this requirement, LFM W8 is inactive against Escherichia coli and Staphylococcus aureus. In order to solve this puzzle, a quantitative structure-antibacterial activity relationship study of synthetic LFM W8 derivatives was performed by replacing the glutamate residues in positions 1 and 9 with arginine or alanine, and the valine residue in position 13 with tyrosine. The results from the study were analyzed using multivariate data analysis. The derived mathematical model clustered the peptides into distinct groups which reflected their antibacterial activities, pointed out correlations between different structural parameters, highlighted the structural parameters that were important for antibacterial activity, and enabled us to predict the activity of a 15-residue bovine lactoferricin derivative. The results showed that net charge and micelle affinity, as determined from the ratio of alpha-helicity in sodium dodecyl sulfate micelles and in 1,1,1,3,3,3-hexafluoro-2-propanol, were the most important structural parameters affecting antibacterial activity. The most active derivative, LFM R1,9 W8 Y13, displayed a minimal inhibitory concentration of 10 and 12 microM against E. coli and S. aureus, respectively. This represented more than 50-fold and 40-fold increases in antibacterial activity, respectively, compared with LFM W8.
Insights
This study investigated synthetic lactoferricin derivatives to enhance antibacterial activity against E. coli and S. aureus. Modifications revealed that net charge and micelle affinity are key factors, leading to significantly more potent compounds.
Area of Science:
- Antimicrobial Peptides
- Medicinal Chemistry
- Structural Biology
Background:
- Lactoferricin derivatives are potent antimicrobial agents, but activity can be modulated by specific amino acid substitutions.
- LFM W8, a synthetic lactoferricin derivative, unexpectedly showed no activity against E. coli and S. aureus despite possessing key tryptophan residues.
Purpose of the Study:
- To elucidate the structure-activity relationship of LFM W8 derivatives against common bacterial pathogens.
- To identify critical structural parameters influencing the antibacterial efficacy of lactoferricin analogs.
Main Methods:
- Quantitative structure-activity relationship (QSAR) analysis of synthetic LFM W8 derivatives with modified glutamate and valine residues.
- Multivariate data analysis to correlate structural changes with antibacterial activity.
- Determination of micelle affinity and alpha-helicity in different environments.
Main Results:
- A mathematical model successfully clustered peptides based on antibacterial activity and identified key structural determinants.
- Net charge and micelle affinity emerged as the most significant factors impacting antibacterial potency.
- The derivative LFM R1,9 W8 Y13 demonstrated a substantial increase in activity, with minimal inhibitory concentrations of 10 µM against E. coli and 12 µM against S. aureus.
Conclusions:
- Antibacterial activity of lactoferricin derivatives is strongly influenced by net charge and micelle binding affinity.
- Strategic amino acid modifications can significantly enhance the potency of synthetic lactoferricin analogs.
- This research provides a predictive model for designing novel, highly active antimicrobial peptides.